Stay updated on Atacicept in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.

Latest updates to the Atacicept in IgA Nephropathy Clinical Trial page
- Check5 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content and navigation with an access-restricted message. This reflects an access restriction rather than a substantive change to the study information.SummaryDifference17%

- Check26 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, signaling a newer version of the page; this appears to be an administrative update rather than a substantive change to the study details.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page revision label has been updated to v3.6.6, indicating a minor platform or content-management update rather than a change to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedThe status changed from 'No Results Posted' to 'Results Submitted', indicating that the study's results have been submitted to ClinicalTrials.gov and are in the submission process.SummaryDifference0.1%

- Check62 days agoChange DetectedA new publication citation for the ORIGIN Phase 2b results was added to the Publications section, listing authors and bibliographic details. The note indicating no abstract was available for that publication was removed.SummaryDifference0.1%

Stay in the know with updates to Atacicept in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atacicept in IgA Nephropathy Clinical Trial page.